Just after 12 o’clock today, the creditors of medical diagnostics firm HiberGene Diagnostics logged on to a virtual meeting to liquidate the company. Even before the meeting started, most participants knew it would be a testy affair. The once-promising company had raised more than €15 million from investors and had 13 products in its armoury. However, undone by an inability to convert products into enough revenue and ongoing shareholder strife, the directors opted to call in the liquidator. As Francesca has previously reported, management have blamed dissenters for leaking confidential information to the media, something they say damaged HiberGene’s reputation…

Join The Currency

INTRODUCTORY OFFER.

Sign up today: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 3,700 exclusive interviews, investigations, and analysis, plus over 360 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.